DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Nihonbashi Life Science HUB

2026年7月30日 (木) 午後 1:00 - 2026年7月30日 (木) 午後 8:00

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

6th DIA COMMUNITY DAY

概要

6th Community Day will be conducted in Japanese Language only.

Click Here to View the Flyer in Japanese

 

When you are applying, please be sure to answer the questionnaire at the link below for group assignment.

https://forms.gle/TQzvgjTnxJe39A6u9

 

プログラム委員会

  • Kotone  Matsuyama, RPH
    Kotone Matsuyama, RPH Center for Clinical Research and Development
    National Center for Child Health and Development, Japan
  • So  Miyoshi
    So Miyoshi Head of Clinical Pharmacology & Bioanalytics
    Pfizer R&D Japan, Japan
  • Keiko  Tsumori, MSC
    Keiko Tsumori, MSC Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
    MSD K.K., Japan
  • Naoki  Isogawa, PHD
    Naoki Isogawa, PHD Biometrics & Quantitative Sciences East Asia (BQS), Head of BQS East Asia
    UCB Japan Co., Ltd., Japan
  • Yoichi M.  Ito, PHD
    Yoichi M. Ito, PHD Director
    Hokkaido University Hospital, Institute of Health Science Innovation, Japan
  • Masaaki  Jitsu
    Masaaki Jitsu
    Bayer Yakuhin Ltd, Japan
  • Yusuke  Kajimoto
    Yusuke Kajimoto Senior Scientist, Scientific Affairs
    MSD K.K., Japan
  • Keiko  Katsui, PHD
    Keiko Katsui, PHD Division of Biomedical Ethics and Social Co-Creation
    Japan Agency for Medical Research and Development (AMED), Japan
  • Kentaro  Kogushi, PHD
    Kentaro Kogushi, PHD Head of Clinical Development Neurology-Psychiatry, Japan Development
    AbbVie GK, Japan
  • Misato  Kuwagaki, MS
    Misato Kuwagaki, MS Associate Director, Japan Data Sciences, Medical Sciences
    Eli Lilly Japan K.K., Japan
  • Mika  Maeda
    Mika Maeda Lecturer, Section for Human Research Protections, Kitasato University Hospital
    School of Pharmacy, Kitasato University, Japan
  • Kana  Maruyama
    Kana Maruyama Manager, Regulatory Labeling, Regulatory Affairs
    Viatris Pharmaceuticals Japan GK, Japan
  • Makoto  Nagaoka, PHD
    Makoto Nagaoka, PHD Senior Director, Global Regulatory Affairs Strategy, Consulting
    Fortrea Japan K.K., Japan
  • Tomoharu  Numanyu, RPH
    Tomoharu Numanyu, RPH Senior Reviewer, Office of New Drug I
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Hiromi  Okabe, PHD
    Hiromi Okabe, PHD Oncology & Rare Disease, Regulatory Strategy, Regulatory Affairs
    Amgen K.K., Japan
  • Daiju  Okuda, PHARMD
    Daiju Okuda, PHARMD Deputy Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Takashi  Sato, MSC, PMP
    Takashi Sato, MSC, PMP
    PM Orchestra Takashi Sato, Japan
  • Keisuke  Suzuki, PHD
    Keisuke Suzuki, PHD Director, Innovation Center for Translational Research
    National Center for Geriatrics and Gerontology, Japan
  • Satoshi  Suzuki, PMP
    Satoshi Suzuki, PMP Director, Head of PM Office Group, Japan Portfolio & Project Management
    Pfizer R&D Japan G.K., Japan
  • Tadashi  Urashima, PHD
    Tadashi Urashima, PHD Performance and Digital Analytics Lead, Japan Development
    GlaxoSmithKline K.K., Japan
  • Miyoko  Yamauchi
    Miyoko Yamauchi Head, Human Capital Development Group
    CHUGAI PHARMACEUTICAL CO., LTD., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。